FDA Drug Recalls

Recalls / Class II

Class IID-0228-2018

Product

Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle, RX Only, Manufactured by: Unichem Laboratories Ltd. Ind. Area, Meerut Road, Ghaziabad-201 003, India. Marketed By: Unichem Pharmaceuticals (USA), Inc. Hasbrouck Heights, NJ 07604. NDC 29300-140-01

Brand name
Divalproex Sodium
Generic name
Divalproex Sodium
Active ingredient
Divalproex Sodium
Route
Oral
NDCs
29300-138, 29300-139, 29300-140
FDA application
ANDA079163
Affected lot / code info
Lot: ZDPH17040

Why it was recalled

Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.

Recalling firm

Firm
Unichem Pharmaceuticals Usa Inc
Manufacturer
Unichem Pharmaceuticals (USA), Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
777 Terrace Ave, Suite 102, Hasbrouck Heights, New Jersey 07604-3102

Distribution

Quantity
96,876 Bottles of 30s
Distribution pattern
Product was distributed nationwide in the USA.

Timeline

Recall initiated
2017-12-19
FDA classified
2018-01-17
Posted by FDA
2018-01-24
Terminated
2018-09-12
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0228-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Divalproex Sodium · FDA Drug Recalls